1 unchanged sentence
3.1 Ninth Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on March 28, 2014).
−Removed: 3.2 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed on March 28, 2014).
3.2 Certificate of Amendment of Ninth Amended and Restated Certificate of Incorporation of Akebia Therapeutics, Inc.
(incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed on June 9, 2020).
−Removed: 10.1† Non-Employee Director Compensation Program, effective January 26, 2021 (incorporated by reference to Exhibit 10.19 to the Company 's Ann ual Report on Form 10-K , filed on February 25, 2021 ) .
−Removed: 10.2 Amendment No.
−Removed: 2 to Master Manufacturing Services and Supply Agreement, dated as of January 29, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc.
−Removed: (incorporated by reference to Exhibit 10.
−Removed: 58 to the Company's Annual Report on Form 10-K, filed on February 25, 2021) .
−Removed: 10.3# Amendment No.
−Removed: 3 to Master Manufacturing Services and Supply Agreement, dated as of February 11, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc.
−Removed: (incorporated by reference to Exhibit 10.
−Removed: 5 9 to the Company's Annual Report on Form 10-K, filed on February 25, 2021)
−Removed: 10.4*# Supply Agreement, dated February 10, 2021, by and between the Company and STA Pharmaceutical Hong Kong Limited.
−Removed: 10.5*# Royalty Interest Acquisition Agreement, dated February 25, 2021, by and between the Company and HealthCare Royalty Partners IV, L.P.
+Added: 3.3 Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed on March 28, 2014).
+Added: 10.1*# Amendment #1 to the Supply Agreement, dated as of April 15, 2021, by and between Akebia Therapeutics, Inc, and STA Pharmaceutical Hong Kong Limited.
31.1* Certification of Principal Executive Officer Required Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
9 unchanged sentences
* Filed, or submitted electronically, herewith
−Removed: † Indicates management contract or compensatory plan
# Indicates portions of the exhibit (indicated by asterisks) have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K
1 unchanged sentence
AKEBIA THERAPEUTICS, INC.
−Removed: May 10, 2021 By:
+Added: August 5, 2021
President and Chief Executive Officer (Principal Executive Officer)
−Removed: May 10, 2021 By:
+Added: August 5, 2021
Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)
−Removed: May 10, 2021 By:
+Added: August 5, 2021
/s/ Violetta Cotreau
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.